Global Bipolar Disorder Market Expected to Witness a Sustainable Growth over 2025 - QY Research

This report focuses on the global Bipolar Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bipolar Disorder development in United States, Europe and China.

Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity levels.

People suffering with bipolar disorder have intense emotional states that occur in distinct periods called mood episodes. Mood episode is characterized by drastic changes in person’s usual mood and their behavior. Mood episode is mainly classified into two main types: manic episodes and depressive episodes. An overexcited or joyful state is called a manic episode and an extremely hopeless or sad state is called a depressive episode. Sometimes, a mood episode includes symptoms of both depression and mania, known as mixed state. These mood episodes hamper school and job performance.

The key players covered in this study

    Glaxo SmithKline (GSK)

    Pfizer

    Janssen Pharmaceuticals

    Eli Lilly

    Allergan

    Novartis

    AbbVie

    Otsuka

    AstraZeneca

Market segment by Type, the product can be split into

    Selective Serotonin Reuptake Inhibitor

    Serotonin Norepinephrine Reuptake Inhibitors

    Tricyclic Antidepressants

    Monoamine Oxidase Inhibitors

    Benzodiazepines

    Beta Blockers

Market segment by Application, split into

    Mood Stabilizers

    Anticonvulsants

    Antipsychotic drugs

    Antidepressant drugs

    Antianxiety drugs

Market segment by Regions/Countries, this report covers

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

    Central & South America

The study objectives of this report are:

    To analyze global Bipolar Disorder status, future forecast, growth opportunity, key market and key players.

    To present the Bipolar Disorder development in United States, Europe and China.

    To strategically profile the key players and comprehensively analyze their development plan and strategies.

    To define, describe and forecast the market by product type, market and key regions.

Request Sample Report and TOC@ http://www.qyresearchglobal.com/goods-1792568.html

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research Achievements:  

Year of Experience: 11 Years

Consulting Projects: 500+ successfully conducted so far

Global Reports: 5000 Reports Every Years

Resellers Partners for Our Reports: 150 + Across Globe

Global Clients: 34000+

Contact US

QY Research, INC.

Tina

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442

Email: sales@qyrsearchglobal.com 

Web: www.qyresearchglobal.com

For other region, contact number given below

+86 108 294 5717 Beijing

+852 3062 8839 HK

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Room 2901 VILI International Building No.167 Linhe West Road

This release was published on openPR.